A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...

Background The lower airway microbiota in patients with chronic obstructive pulmonary disease (COPD) are likely altered compared with the microbiota in healthy individuals. Information on how the ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

RATIONALE Plasma fibrinogen and C-reactive protein (CRP) are acute phase reactants that are increasingly being investigated as potential biomarkers for COPD severity, progression, and exacerbation ...

Establishing the diagnosis may be challenging, and no diagnostic criteria exist. The diagnosis is based on a constellation of symptoms and clinical findings such as decreased function of exocrine ...

There are a wide range of behaviors and symptoms in patients with eating disorders that are not captured by current diagnostic criteria, new research suggests.

Predicting COPD exacerbations In a pilot study, Drummond and his colleagues examined whether the ProAir Digihaler can help predict an impending COPD exacerbation. The researchers remotely enrolled 55 ...

Commentary on an important review and meta analysis to evaluate the effectiveness of emergency treatments for COPD.

Assessing α-synuclein SAA kinetic measures might aid in the diagnostic differentiation of Parkinson's disease from progressive supranuclear palsy with Lewy body co-pathology. Furthermore, faster ...

This study proposes Copd-ChatGLM, a large language model fine-tuned for COPD diagnosis and management using the RAG framework. The model combines deep learning with clinical data to enhance diagnostic ...

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...